retatrutide clinical trials dosage trial dosing frequency microdosing: guide to split protocols and schedules The Retatrutide Chart: A – Retatrutide 10 mg: vial guide

95% CI, 0.31 to 7.34

Substantial Weight Reduction In a 48-week Phase 2 obesity trial, participants receiving retatrutide 12 mg once weekly reached an average 24.2% body weight reduction , with weight loss continuing through the study period rather than plateauing early

Choi JG, Winn AN, Skandari MR, et al

Why Hair Loss Can Occur After Starting Ozempic Most hair shedding reported during GLP-1 treatment is related to telogen effluvium , a temporary condition where more hair follicles shift into the resting phase of the growth cycle

Orforglipron may join the list of oral GLP-1s soon

As lean mass preservation gains prominence in scientific discussion, therapies that can demonstrate muscle-sparing propertieswhether through receptor selectivity, combination approaches, or adjunct treatmentswill claim meaningful differentiation